Impact of miR-92a on Acute Leukemia
Author Information
Author(s): Ohyashiki Junko H, Umezu Tomohiro, Kobayashi Chiaki, Hamamura Ryoko S, Tanaka Masami, Kuroda Masahiko, Ohyashiki Kazuma
Primary Institution: Tokyo Medical University
Hypothesis
Does miR-92a expression in plasma reflect its levels in leukemia cells?
Conclusion
miR-92a expression in leukemia cells could be a prognostic factor in ALL patients.
Supporting Evidence
- miR-92a expression was significantly lower in acute leukemia compared to normal controls.
- ALL patients with overexpressed miR-92a had poor prognoses.
- The cell to plasma ratio of miR-92a was significantly higher in both AML and ALL cells compared to healthy controls.
Takeaway
This study looks at a molecule called miR-92a in leukemia patients to see if it can help doctors understand the disease better.
Methodology
The study involved measuring miR-92a levels in leukemia cells and plasma from 91 patients using reverse transcription polymerase chain reaction.
Limitations
The study could not determine the clinical relevance of miR-92a when analyzing only a cell fraction of AML.
Participant Demographics
Patients aged 17-72 years with untreated, primary acute leukemia.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website